Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.83
+0.05 (0.64%)
Sep 25, 2026, 11:16 AM CET
Mabion Market Cap
Mabion has a market cap or net worth of 125.74 million as of September 24, 2026. Its market cap has decreased by -13.07% in one year.
Market Cap
125.74M
Enterprise Value
152.39M
Revenue
17.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.83
ChartMarket Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 125.74M, an increase of 35.19%. That is a compound annual growth rate of 1.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 125.74M | 11.46% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 627.97M |
| Captor Therapeutics Spolka Akcyjna | 451.73M |
| Bioceltix | 417.69M |
| Ryvu Therapeutics | 369.92M |
| BIOTON | 310.40M |
| Synthaverse | 219.36M |
| Molecure | 160.70M |
| Poltreg | 120.10M |